Targeting <i>RB1</i> Loss in Cancers
Retinoblastoma protein 1 (RB1) is encoded by a tumor suppressor gene that was discovered more than 30 years ago. Almost all mitogenic signals promote cell cycle progression by braking on the function of RB1 protein through mono- and subsequent hyper-phosphorylation mediated by cyclin-CDK complexes....
Main Authors: | Paing Linn, Susumu Kohno, Jindan Sheng, Nilakshi Kulathunga, Hai Yu, Zhiheng Zhang, Dominic Voon, Yoshihiro Watanabe, Chiaki Takahashi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/15/3737 |
Similar Items
-
Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response
by: Jayaprakash Mandal, et al.
Published: (2022-09-01) -
A genetic map of the chromatin regulators to drug response in cancer cells
by: Bo Chen, et al.
Published: (2022-09-01) -
Synthetic Genetic Targeting of Genome Instability in Cancer
by: Kirk J. McManus, et al.
Published: (2013-06-01) -
Synthetic Vulnerabilities in the KRAS Pathway
by: Marta Roman, et al.
Published: (2022-06-01) -
RAD52 as a Potential Target for Synthetic Lethality-Based Anticancer Therapies
by: Monika Toma, et al.
Published: (2019-10-01)